9 | FibrinIBA
01/2022
-
11/2014 |
5 | estropipate (Ogen)FDA LinkGeneric
01/2022
-
06/2016 |
4 | 1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA
11/2021
-
01/2016 |
4 | Proteins (Proteins, Gene)FDA Link
11/2021
-
01/2009 |
4 | ThrombinFDA Link
01/2018
-
11/2014 |
3 | Blood Coagulation Factors (Coagulation Factor)IBA
01/2022
-
05/2014 |
3 | Hemostatics (Antihemorrhagics)IBA
11/2021
-
06/2016 |
3 | Polychlorinated Dibenzodioxins (TCDD)IBA
12/2016
-
10/2011 |
3 | Drinking WaterIBA
07/2012
-
09/2011 |
3 | chromium hexavalent ionIBA
07/2012
-
09/2011 |
2 | Carbon Tetrachloride (Tetrachloromethane)IBA
11/2021
-
01/2017 |
2 | von Willebrand FactorIBA
11/2021
-
01/2017 |
2 | Fibrinogen (Factor I)FDA Link
01/2019
-
08/2017 |
2 | Acetaminophen (Paracetamol)FDA LinkGeneric
01/2018
-
01/2017 |
2 | Peptide Hydrolases (Proteases)FDA Link
01/2018
-
12/2016 |
2 | Plasminogen Activators (Plasminogen Activator)IBA
01/2018
-
06/2014 |
2 | AntithrombinsIBA
08/2017
-
11/2014 |
2 | DabigatranFDA Link
08/2017
-
11/2014 |
2 | XenobioticsIBA
01/2017
-
01/2016 |
2 | Messenger RNA (mRNA)IBA
01/2017
-
10/2014 |
2 | Trichloroethylene (Trichloroethene)IBA
01/2017
-
10/2014 |
2 | CytokinesIBA
12/2016
-
01/2016 |
2 | Collagen Type I (Type I Collagen)IBA
10/2014
-
01/2009 |
2 | 2,4,5,2',4',5'-hexachlorobiphenylIBA
10/2011
-
03/2010 |
1 | EnzymesIBA
12/2020 |
1 | Silicon Dioxide (Silica)FDA LinkGeneric
01/2018 |
1 | Docosahexaenoic AcidsIBA
01/2018 |
1 | Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2018 |
1 | CaspasesIBA
01/2018 |
1 | AutoantibodiesIBA
01/2018 |
1 | Plasminogen Activator Inhibitor 1IBA
01/2018 |
1 | Factor Xa (Coagulation Factor Xa)IBA
01/2018 |
1 | Tissue Plasminogen Activator (Alteplase)FDA Link
01/2018 |
1 | Protease Inhibitors (Protease Inhibitor)IBA
01/2018 |
1 | Glucose (Dextrose)FDA LinkGeneric
08/2017 |
1 | ThrombomodulinIBA
08/2017 |
1 | AntibodiesIBA
01/2017 |
1 | Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
01/2017 |
1 | Interleukin-6 (Interleukin 6)IBA
12/2016 |
1 | Thrombin Receptors (Thrombin Receptor)IBA
12/2016 |
1 | AnticoagulantsIBA
06/2016 |
1 | Clopidogrel (Plavix)FDA Link
01/2016 |
1 | InterferonsIBA
01/2016 |
1 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2016 |
1 | IntegrinsIBA
01/2016 |
1 | leukadherin-1IBA
01/2016 |
1 | Purinergic P2Y Receptor AntagonistsIBA
01/2016 |
1 | TransglutaminasesIBA
01/2016 |
1 | Transcription Factors (Transcription Factor)IBA
01/2015 |
1 | Oxygen (Dioxygen)IBA
01/2015 |
1 | Bile Acids and Salts (Bile Acids)IBA
11/2014 |
1 | Pharmaceutical PreparationsIBA
06/2014 |
1 | Tranexamic Acid (AMCA)FDA Link
06/2014 |
1 | Antifibrinolytic Agents (Antifibrinolytics)IBA
06/2014 |
1 | Alanine Transaminase (SGPT)IBA
10/2013 |
1 | dibenzo(1,4)dioxinIBA
10/2013 |
1 | sodium bichromate (sodium dichromate)IBA
02/2012 |
1 | Focal Adhesion Protein-Tyrosine KinasesIBA
01/2009 |
1 | CollagenIBA
01/2009 |
1 | 3,4,5,3',4'-pentachlorobiphenylIBA
03/2008 |